PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: CSO Precision Medicine Presentation, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,075 Posts.
    lightbulb Created with Sketch. 43
    Agree with your last 3 posts Philley (must add, all of your posts to date).
    Definitely looking forward to the AML results (as many here are), highly promising and may even surpass expectations. As you have previously stated, the likelihood of a ‘major’ re-rate is on the cards.
    Will the oppies manifest into ordinary shares (heads)?
    Million dollar question. Timing appears to be the main factor with the minor efficacy of results.
    Although 10mil additional to the kitty would be great, partnering with either the breastcancer study and/or the (potential) AML forthcoming results would not be out of the blue either.
    Within a couple of months, in hindsight the current SP should be well and truely behind us.
    Still topping up bit by bit (borrowing the line from free2nap here), always wishing more.
    Luck to all holders and welcoming new holders alike.
    Sorry I cannot add any chart knowledge here, maybe Maxter can accomodate.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.